Dr. Prashant Vilas Bhangui

Dr. Prashant gained experience in Surgical Gastroenterology and Liver Transplantation at two of the most reputed Institutes in India G.B. Pant Hospital and Sir Gangaram Hospital, New Delhi. He then successfully completed a Masters Programme in HPB Surgery and Liver Transplantation at the Henri Bismuth Hepatobiliary Institute in France followed by a Fellowship Programme at Centre Hepatobiliare Hopital Paul Brouse Paris. He holds a European Inter University Diploma in Hepato-Biliary-Pancreatic Cancers: Oncosurgical Strategies and was awarded the Merck KGaA Germany International Educational Grant for clinical research. Dr. Prashant’s areas of special interest include hepatocellular carcinoma colorectal liver metastases and living donor liver transplantation and he has several publications in key peer reviewed International journals on these subjects. He is also on the Reviewer Panel for Journal Of Hepatology Liver Transplantation World Journal Of Surgery. Dr. Prashant’s key areas of research include molecular markers and newer therapies in management of hepatocellular carcinoma and colorectal liver metastases.

• Masters in Hepatobiliary & Pancreatic Surgery Henri Bismuth Hepatobiliary Institute, Villejuif, France 2009

• European Inter University Diploma in Hepato-Biliary-Pancreatic Cancers: Oncosurgical Strategies Universite Paris XI, France 2009

• M.S. (General Surgery) Goa Medical College 2004

• M.B.B.S. Goa Medical College 2000

• Vanguard Award 2016” for Best Published Clinical Research Paper of the year by the International Liver Transplant Society (ILTS), 2016

• "Dr. K.N. Udupa Memorial Oration 2016” for Outstanding Research and contributing to the development of Organ Transplantation in India, Indian Society of Organ Transplantation (ISOT), 2016

• Best paper award, 2nd Congress of the International Living Donor Liver Transplantation Study Group, Seoul,South Korea, 2015

• Award papers at the 20th Annual International Congress of ILTS, London, , 2014

• MERCK KGaA Germany, International Student Educational Grant further to Masters in Hepatobiliary Surgery and Liver Transplantation for clinical research work in the field of colorectal liver metastases.

• Award papers at the 1st International Congress of the International Living Donor Liver Transplant Study Group (ILDLT) held in Seoul,Korea, 2014

• Award papers at the XXII Annual Conference of the Indian Association of Surgical Gastroenterology, Bengaluru, India, 2012

• Award paper at the 19th Annual International Congress of the ILTS, Sydney, 2013; 18th Annual International Congress ILTS, San Francisco, 2012.

• International Liver Transplantation Society (ILTS), Member VANGUARD COMMITTE

• European Society for Organ Transplantation (ESOT) and European Liver Transplant Association(ELITA)

• American Association for the Study of Liver Diseases (AASLD)

• The Transplantation Society (TTS), Member EDUCATION COMMITTEE

• International Living Donor Liver Transplant (ILDLT) Study Group

• International Association of Surgeons, Gastroenterologists, Oncologists (IASGO)

• Indian Society for Organ Transplantation (ISOT)

• On the Reviewers Panel for various peer reviewed journals including Liver Transplantation, World

• Journal Of Surgery, Journal Of Hepatology.

• Ann Surg. 2016;264:155-63 : Salvage Versus Primary Liver Transplantation for Early Hepatocellular Carcinoma: Do Both Strategies Yield Similar Outcomes?, 2016

• Am J Transplant. 2016;16:143-56. : Integrum Functional and Volumetric Recovery in Right Lobe Living Donors: Is It Really Complete 1 Year After Donor Hepatectomy?, 2016

• HPB (Oxford) 2017;19:638 648 : The impact of expanded indications on short term outcomes for resection of malignant tumours of the liver over a 30 year period.,

• Ann Surg. 2016 Sep 9. [Epub ahead of print] : Living or Brain-dead Donor Liver Transplantation for Hepatocellular Carcinoma: A Multicenter, Western, Intent-to-treat Cohort Study, 2016

• Clin Transplant. 2017:31:5. : (D+10) MELD as a novel predictor of patient and graft survival after adult to adult living donor liver transplantation,

• Clin Transplant. 2017 May 12 : High MELD score does not adversely affect outcomesof Living Donor Liver Transplantation: Experience in 1000 recipients, 2012

• J Transplant. 2016 Dec 24;6(4): 703-711 : Quality of life 10 years after liver transplantation: The impact of graft histology, 2016

• Clin Transplant. 2017;31:3 : Good outcome of living donor liver transplantation in drug-induced acute liver failure: A single center experience,

• Ann Surg 2015;261:e109-10. : “Resection or Transplantation for Early Hepatocellular Carcinoma in a Cirrhotic Liver: Does Size Define the Best Oncological Strategy?”, 2015

• Ann Surg 2015 Feb;261(2):e48 : Multivisceral Transplantation for diffuse portomesenteric thrombosis., 2015

• HPB (Oxford). 2014;Aug;16(8):723-38 : Portal Vein Arterialization: a salvage procedure for a totally de-arterialized liver. The Paul Brousse Hospital Experience, 2014

• Indian J Gastroenterol. 2016 Nov; 35(6):465-468 : Impact of endoscopic ultrasound guided fine-needle aspiration in prospective liver transplant recipients with hepatocellular carcinoma and lymphadenopathy, 2016

• Transplant Proc. 2016 Oct;48(8):2732-2737. : Hepatic Venous and Inferior Vena Cava Morphology No Longer a Barrier to Living Donor Liver Transplantation for Budd-Chiari Syndrome: Surgical Techniques and Outcomes., 2016

• Clin Transplant. 2017 Mar; 31(3) : Good outcome of living donor liver transplantation in drug induced acute liver failure: a single centre experience,

• Clin Transplant. 2017 Apr;31(4). : Prediction of nonalcoholic fatty liver in prospective liver donors.,

• Indian J Gastroenterol. 2016;35:113-6. : Intragastric balloon as a novel modality for weight loss in patients with cirrhosis and morbid obesity awaiting liver transplantation,

• Indian J Gastroenterol. 2016;35:123-8 : Lower Relapse rates with good post-transplant outcome in alcoholic liver disease: Experience from a living donor liver transplant center,

• Eur J Gastroenterol Hepatol. 2016;28:441-3. : Nonalcoholic fatty liver is not associated with incident chronic kidney disease: a large histology-based comparison with healthy individuals.,

• Indian J Gastroenterol. 2015;34:305-9. : Genotype 3 and higher low-density lipoprotein levels are predictors of good response to treatment of recurrent hepatitis C following living donor liver transplantation,

• J Clin Exp Hepatol. 2015;5:123-6. : Rapid Reversal of Liver Steatosis With Life Style Modification in Highly Motivated Liver Donors.,

• Indian J Gastroenterol. 2014; 33:72-6. : The use of ABO-incompatible grafts in living donor liver transplantation – first report from India,

• Indian J Gastroenterol. 2014;33:104-13 : India’s first successful intestinal transplant: the road travelled and the lessons learnt.,

• Ann Surg. 2012;256:883-91 : Resection or Transplantation for Early Hepatocellular Carcinoma in a Cirrhotic Liver: Does Size Define the Best Oncological Strategy?,

• J Hepatol. 2012;57:874-84. : Assessment of risk for nonhepatic surgery in cirrhotic patients,

• Ann Surg. 2011 Dec;254(6):1008-16. : Inflow to the Graft for Liver Transplantation in Patients With Diffuse Portal Vein Thrombosis: A 12-Year Experience,

• Hepatology. 2011;53:1570-9. : Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: living versus deceased donor transplantation.,

• Am J Transplant. 2011;11:101-10. : Short- and long-term donor morbidity in right lobe living donor liver transplantation: 91 consecutive cases in a European Center.,

• European Oncology 2010;6:37-40 : Liver Resection of Colorectal Metastases in Elderly Patients,

• Surg Endosc. 2011;25:1858-65. : Results of percutaneous manoeuvres in biliary disease:the Paul Brousse experience,

• Ann Surg. 2010;252:774-87 : Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases?,

• Cancer News (Rajiv Gandhi Cancer Institute and Research Centre) 2011;5:6-9. : Liver Transplantation for Hepatocellular Carcinoma.

•